By Heejin Kim SEOUL, May 4 (Reuters) - South Korean contract drug manufacturer Samsung Biologics estimated a strike by its labour union over pay that started late last month has cost the company about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results